Skip to main content
. Author manuscript; available in PMC: 2015 Dec 3.
Published in final edited form as: Ann Med. 2015 Apr 9;47(3):245–252. doi: 10.3109/07853890.2015.1019916

Table 1.

Dichotomous and continuous variables between AAA patients and controls and their associations with plasma medians of IL6, IFN-γ, IL10, IL17A, and CRP levels.

Dichotomous variables AAA vs. Non-AAAa (OR [95% CI]) IL6 (25. 50. and 75 Percentiles) (No vs. Yes)b IFN-γ (25. 50. and 75 Percentiles ) (No vs. Yes)b IL10 (25. 50. and 75 Percentiles ) (No vs. Yes)b IL17A (25. 50. and 75 Percentiles ) (No vs. Yes)b CRP 25. 50. and 75 Percentiles) (No vs. Yes)b
Current smoking 3.44 [2.31; 5.13]*** 0.00; 1.35; 4.277
0.00; 1.42; 3.49*
6.35; 6.88; 46.8
5.52; 13.96; 40.32
0.00; 11.0; 62.0
0.00; 0.00; 0.00
0.00; 0.00; 0.00
0.00; 0.00; 10.1
1.1; 2.3; 4.9
1.7; 3.8; 7.7***
Diabetes Mellitus 0.70 [0.44; 1.11] 0.00; 1.42; 4.52
0.00; 1.03; 3.37
6.22; 17.1; 47.1
5.92; 14.6; 44.6
0.00; 10.7; 69.7
0.04; 14.0; 104.8
0.00; 0.00; 11.1
0.00; 0.00; 10.5
1.4; 2.7;5.6
0.9; 2.6; 6.1
Hypertension 1.52 [1.10; 2.10]*** 0.00; 1.32; 3.75
0.00; 1.40; 4.88
6.44; 17.2; 43.2
6.22; 16.1; 56.6
0.00; 12.1; 86.0
6.22; 16.17; 56.6
0.00; 0.00; 11.1
0.00; 0.00; 10.46
1.4; 2.6; 5.2
1.4;2.7;6.2
Use of ACE-inhibitor 1.35 [0.92; 1.98] 0.00; 1.15; 4.26
0.00; 1.64; 4.83
5.99; 17.4; 46.8
6.61; 15.0; 55.2
0.00; 10.9; 84.60
0.00; 9.16; 60.8
0.00; 0.00; 13.9
0.00; 0.00; 8.90
1.4; 2.6;5.3
1.3; 2.7; 6.5
Use of β-blocker 1.49 [1.02; 2.17]** 0.00; 1.10; 3.75
0.00; 1.85; 5.86*
5.87; 16.4; 44.2
7.10; 19.2; 62.0
0.00; 10.7; 71.8
0.00; 11.6; 74.7
0.00; 0.00; 9.95
0.00; 0.00; 10.5
1.4; 2.6; 5.5
1.3; 2.7; 6.0
Use of statin 2.15 [1.54; 2.99]*** 0.00; 1.19; 3.96
0.00; 1.47; 4.86
6.80; 18.2; 51.6
5.45; 15.0; 42.0*
0.00; 11.0; 87.8
5.45; 15.0; 42.1
0.00; 0.00; 13.9
0.00; 0.00; 9.83
1.5; 2.9; 6.5
1.1;2.4; 5.0***
Use of steroids 1.53 [0.78; 3.03] 0.00; 1.23; 4.58
0.00; 1.58; 4.01
6.00; 15.9; 47.1
7.34; 21.2; 44.6
0.00; 11.5; 76.2
0.00; 8.18; 44.1
.0.00; 0.00; 10.4
0.00; 0.00; 14.0
1.3; 2.4; 5.3
2.1; 5.1; 8.6***
Use of NSAIDs 9.07 [1.22; 67.50]*** 0.00; 1.33; 4.60
0.00; 1.02; 2.28
6.08; 17.1; 48.4
4.07; 10.3; 25.5
0.00; 17.8; 76.2
0.00; 8.47; 46.0
0.00; 0.00; 9.78
0.00; 2.63; 27.7
1.3; 2.6; 5.6
1.0; 2.6; 9.3
Continuous variables 25. 50. and 75 Percentiles
Non-AAA vs. AAAb
IL6 (Rho)c IFN-γ (Rho)c IL10 (Rho)c IL17A (Rho)c CRP (Rho)c
Systolic blood pressure (mmHg) 137; 146; 159
142; 155; 169***
-0.025 -0.042 -0.103*** -0.073 -0.006
Diastolic blood pressure (mmHg) 74; 80; 87
79; 87; 95***
-0.001 -0.037 -0.067* -0.017 0.098**
Age (Years) 67.2; 69.3; 71.9
67.6; 69.9; 72.4**
0.011 -0.033 -0.048 -0.036 -0.024
Body mass index 24.4; 25.9; 27.6
24.9; 27.2; 29.4***
-0.018 -0.012 -0.012 0.001 0.137***
a

Chi-square test;

b

Mann-Whitney U test;

c

Spearman's correlation test.

*

P<0.10 (considered as confounding factor);

**

P<0.05;

***

P<0.01